The trademark application PIVANEX was filed by Titan Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 11, 2005, and still open for oppositions.
The application was filed in English (Spanish was selected as the second language).
Change of name and professional address of the trademark registration was recorded on March 18, 2011.